Skip to main content
. 2022 Jan 25;13:214–223. doi: 10.18632/oncotarget.28182

Figure 1. Study design.

Figure 1

Subanalysis: 174 patients MPO and Gal-3. Chemotherapy protocol: cyclophosphamide, doxorubicin, paclitaxel. Cumulative ANT (doxorubicin) dose: 240 mg/m2.